Neuroprotective effect of 3,5-di-O-caffeoylquinic acid on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase-1

Neuroscience

Volumn 169, Issue 3, 2010, Pages 1039-1045

  Han, J ^a   Miyamae, Y ^a   Shigemori, H ^a   Isoda, H ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

3,5 di O caffeoylquinic acid; ATP; Glycolysis; PGK1; SAMP8; SH SY5Y

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN[1-42]; CYNARINE; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; DOWN REGULATION; DRUG EFFICACY; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SENESCENCE; SWIMMING; TREATMENT RESPONSE; UPREGULATION;

EID: 77955268115     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.05.049     Document Type: Article

References (42)

1. Angenstein F., Evans A.M., Settlage R.E., Moran S.T., Ling S., Klintsova A.Y., Shabanowitz J., Hunt D.F., Greenough W.T. A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons. J Neurosci 2002, 22:8827-8837.
2. Basnet P., Matsushige K., Hase K., Kadota S., Namba T. Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol Pharm Bull 1996, 19:1479-1484.
3. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995, 38:357-366.
4. Benson D.F., Kubl D.E., Hawkins R.A., Phelps M.E., Cumminge J.L., Tsai S.Y. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 1983, 40:711-714.
5. Blass J.P., Sheu R.K., Cedarbaum J.M. Energy metabolism in disorders of the nervous system. Rev Neurol (Paris) 1988, 144:543-563.
6. Boyd-kimball D., Sultana R., Fai Poon H., Lynn B.C., Casamenti F., Pepeu G., Klein J.B., Butterfield D.A. Proteomic identification of proteins specifically oxidized by intracerebeal injection of amyloid β-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience 2005, 132:313-324.
7. Canback B., Andersson S.G.E., Kurland C.G. The global phylogeny of glycolytic enzymes. Proc Natl Acad Sci U S A 2002, 99:6097-6102.
8. Eckert A., Marques C.A., Keil U., Schussel K., Muller W.E. Increased apoptotic cell death in sporadic and genetic Alzheimer's disease. Ann N Y Acad Sci 2003, 1010:604-609.
9. Fai Poon H., Farr S.A., Thongboonkerd V., Lynn B.C., Banks W.A., Morley J.E., Klein J.B., Butterfield D.A. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Int 2005, 46:159-168.
10. Fai Poon H., Joshi G., Sultana R., Farr S.A., Banks W.A., Morley J.E., Calabrese V., Butterfield D.A. Antisense directed at the A-beta region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res 2004, 1018:86-96.
11. Ferhat L., Charton G., Represa A., Ben Ari Y., Terrossian E., Khrestchatisky M. Acidic calponin cloned from neural cells is differentially expressed during rat brain development. Eur J Neurosci 1996, 8:1501-1509.
12. Gao L., Mejìas R., Echevarrìa M., López-Barneo J. Induction of the glucose-6-phosphate dehydrogenase gene expression by chronic hypoxia in PC12 cells. FEBS Letters 2004, 569:256-260.
13. Haag J., Aigner T. Identification of calponin 3 as a novel Smad-binding modulator of BMP signaling expressed in cartilage. Exp Cell Res 2007, 313:3386-3394.
14. Hagino N., Kobayashi S., Tsutsumi T., Horiuchi S., Nagai R., Setalo G., Dettrich E. Vascular change of hippocampal capillary is associated with vascular change of retinal capillary in aging. Brain Res Bull 2004, 62:537-547.
15. Holliday R. The urgency of research on ageing. Bioessays 1996, 18:89-90.
16. Hosokawa M., Abe T., Higuchi K., Shimakawa K., Omori Y., Matsushita T., Kogishi K., Deguchi E., Kishimoto Y., Yasuoka K., Takeda T. Management and design of the maintenance of SAM mouse strains: an animal model for accelerated senescence and ageassociated disorders. Exp Gerontol 1997, 32:111-116.
17. Huang F., Li W., Zhang B., Cui X., Han Z., Fang Z., Cai S., Yin L., Wang L. Effects of free radicals and amyloid beta protein on the currents of expressed rat receptors in Xenopus oocytes. Chin Med J (Engl) 2001, 114:244-247.
18. Hur J.Y., Soh Y., Kim B.H. Neuroprotective and neurotrophic effects of quinic acids from Aster scaber in PC12 cells. Biol Pharm Bull 2001, 24:921-924.
19. Isoda H., Talorete T.P.N., Han J., Nakamura K. Expression of galectin-3, glutathione S-transferase A2 and peroxiredoxin-1 by nonylphenol-incubated Caco-2 cells and reduction in transepithelial electrical resistance by nonylphenol. Toxicol In Vitro 2006, 20:63-70.
20. Kim J.W., Dang C.V. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 2005, 30:142-150.
21. Kumar V.B., Farr S.A., Flood J.F., Kamlesh V., Franko M., Banks W.A., Morley J.E. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides 2000, 21:1769-1775.
22. Kwon Y.S., Kim K.O., Lee J.H. Chemical constituents of Dipsacus asper (II). Kor J Pharmacogn 2003, 34:128-131.
23. 1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus. Neuroscience 2009, 163:741-749.
24. Li Y.P., Bushnell A.F., Lee C.M., Perlmutter L.S., Wong S.K.F. β-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res 1996, 738:196-204.
25. Martínez T., Pascual A. Identification of genes differentially expressed in SH-SY5Y neuroblastoma cells exposed to the prion peptide 106-126. Eur J Neurosci 2007, 26:51-59.
26. Mazzola J.L., Sirover M.A. Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts. J Neurosci Res 2003, 71:279-285.
27. Meier-Ruge W., Hunziker O., Iwangoff P. Senile dementia: a threshold phenomenon of normal aging?. A contribution to the functional reserve hypothesis of the brain. Ann N Y Acad Sci 1991, 621:104-118.
28. Morley J.E., Kumar V.B., Bernardo A.E., Farr S.A., Uezu K., Tumosa N., Flood J.F. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 2000, 21:1761-1767.
29. Nakajima Y., Shimazawa M., Mishima S., Hara H. Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions. Life Sci 2007, 80:370-377.
30. Nomura Y., Yamanaka Y., Kitamura Y., Arima T., Ohnuki T., Oomura Y., Sasaki K., Nagashima K., Ihara Y. Senescence-accelerated mouse. Neurochemical studies on aging. Ann N Y Acad Sci 1996, 786:410-418.
31. Ohta A., Hirano T., Yagi H., Tanaka S., Hosokawa M., Takeda T. Behavioral characteristics of the SAM-P/8 strain in Sidman active avoidance task. Brain Res 1989, 498:195-198.
32. 1-42 is involved in the altered composition of cellular membrane lipids and the decreased expression of nicotinic receptors in human SH-SY5Y neuroblastoma cells. Neurochem Int 2005, 46:613-621.
33. Roth K.A. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol 2001, 60:829-838.
34. Shapiro T.A., Talalay P. Schistosoma mansoni: Mechanisms in regulation of glycolysis. Exp Parasitol 1982, 54:379-390.
35. Shimano Y. Studies on aging through analysis of the glucose metabolism related to the ATP-production of the senescence accelerated mouse (SAM). Hokkaido Igaku Zasshi 1998, 73:557-569.
36. Sirover M.A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1999, 1432:159-184.
37. Soh Y., Kim J.A., Sohn N.W., Lee K.R., Kim S.Y. Protective effects of quinic acid derivatives on tetrahydropapaveroline induced cell death in C6 glioma cells. Biol Pharm Bull 2003, 26:803-807.
38. Takeda T., Hosokawa M., Takeshita S., Irino M., Higuchi K., Matsushita T., Tomita Y., Yasuhira K., Hamamoto H., Shimizu K., Ishii M., Yamamuro T. A new murine model of accelerated senescence. Mech Ageing Dev 1981, 17:183-194.
39. Tucek S., Rincy J., Dolazal V. Advance in the biology of cholinergic neurons. Adv Neurol 1990, 51:109-115.
40. Wang H., Xu Y., Yan J., Zhao X., Sun X., Zhang Y., Guo J., Zhu C. Acteoside protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell injury. Brain Res 2009, 1283:139-147.
41. Yagi H., Katoh S., Akiguchi I., Takeda T. Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Brain Res 1988, 474:86-93.
42. Zheng L., Roeder R.G., Luo Y. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 2003, 114:255-266.